30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A tumor mRNA-dependent gold nanoparticle-molecular beacon carrier for controlled drug release and intracellular imaging.

      Chemical Communications (Cambridge, England)
      Base Sequence, Breast Neoplasms, metabolism, pathology, Cell Line, Tumor, Delayed-Action Preparations, Doxorubicin, chemistry, Drug Carriers, Gold, Humans, Intracellular Space, Metal Nanoparticles, Molecular Imaging, methods, Oligonucleotide Probes, genetics, RNA, Messenger

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We demonstrate a tumor mRNA-dependent drug carrier for controlled release of doxorubicin (Dox) and intracellular imaging based on gold nanoparticle-molecular beacon. Fluorescent Dox is released effectively and induces apoptosis in breast cancer cells but not in normal cells. Significantly, the release of Dox is correlated positively with the quantities of tumor mRNA, which is according to various stages of tumor progression, and so can decrease effectively side effects of Dox.

          Related collections

          Author and article information

          Comments

          Comment on this article